pD454-SR mouse Alpha-synuclein Citations (3)

Originally described in: MJFF plasmids
Unpublished

---

Articles Citing pD454-SR mouse Alpha-synuclein

Articles
GPR40 agonist ameliorates neurodegeneration and motor impairment by regulating NLRP3 inflammasome in Parkinson's disease animal models. Ha TY, Kim JB, Kim Y, Park SM, Chang KA. Pharmacol Res. 2024 Nov;209:107432. doi: 10.1016/j.phrs.2024.107432. Epub 2024 Sep 21. PubMed
Tet2 loss and enhanced ciliogenesis suppress alpha-synuclein pathology. Quansah E, Vatsa N, Ensink E, Brown J, Cave T, Aguileta M, Schulz E, Lindquist A, Gilliland C, Steiner JA, Escobar Galvis ML, Milciute M, Henderson MX, Brundin P, Brundin L, Marshall LL, Gordevicius J. Acta Neuropathol Commun. 2025 Apr 7;13(1):71. doi: 10.1186/s40478-025-01988-z. PubMed
Proteolytic activities of extracellular vesicles attenuate A-synuclein aggregation. Vekrellis K, Lamprokostopoulou A, Melachroinou K, Kokoli M, Zingkou E, Skarveli M, Kolianou A, Samiotaki M, Sotiropoulou G. NPJ Parkinsons Dis. 2025 Sep 29;11(1):277. doi: 10.1038/s41531-025-01122-9. PubMed

If you have published an article using this material, please email us at to have your article added to this page.